- Home
- MTLS vs ORIC Comparison
MTLS vs ORIC Comparison
Compare MTLS & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTLS
- ORIC
- Stock Information
- Founded
- MTLS 1990
- ORIC 2014
- Country
- MTLS Belgium
- ORIC United States
- Employees
- MTLS N/A
- ORIC N/A
- Industry
- MTLS Computer Software: Prepackaged Software
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- MTLS Technology
- ORIC Health Care
- Exchange
- MTLS Nasdaq
- ORIC Nasdaq
- Market Cap
- MTLS 316.0M
- ORIC 362.9M
- IPO Year
- MTLS 2014
- ORIC 2020
- Fundamental
- Price
- MTLS $5.40
- ORIC $9.35
- Analyst Decision
- MTLS
- ORIC Strong Buy
- Analyst Count
- MTLS 0
- ORIC 8
- Target Price
- MTLS N/A
- ORIC $18.83
- AVG Volume (30 Days)
- MTLS 86.5K
- ORIC 2.0M
- Earning Date
- MTLS 07-30-2025
- ORIC 08-11-2025
- Dividend Yield
- MTLS N/A
- ORIC N/A
- EPS Growth
- MTLS 43.31
- ORIC N/A
- EPS
- MTLS 0.17
- ORIC N/A
- Revenue
- MTLS $291,295,936.00
- ORIC N/A
- Revenue This Year
- MTLS $6.42
- ORIC N/A
- Revenue Next Year
- MTLS $8.33
- ORIC N/A
- P/E Ratio
- MTLS $32.22
- ORIC N/A
- Revenue Growth
- MTLS 6.16
- ORIC N/A
- 52 Week Low
- MTLS $3.93
- ORIC $3.90
- 52 Week High
- MTLS $9.69
- ORIC $14.67
- Technical
- Relative Strength Index (RSI)
- MTLS 51.84
- ORIC 62.84
- Support Level
- MTLS $5.37
- ORIC $8.85
- Resistance Level
- MTLS $5.65
- ORIC $9.54
- Average True Range (ATR)
- MTLS 0.18
- ORIC 0.74
- MACD
- MTLS -0.02
- ORIC -0.07
- Stochastic Oscillator
- MTLS 34.27
- ORIC 50.98
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.